Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EAR NASDAQ:ESTA NASDAQ:INGN NYSE:IVC NASDAQ:SMTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEAREargo$70.50$52.85$1.47▼$8.48$1.46B1.523,347 shsN/AESTAEstablishment Labs$37.47-0.9%$40.85$26.56▼$50.85$1.10B0.85255,286 shs313,935 shsINGNInogen$8.54-0.2%$7.27$5.70▼$12.91$231.47M1.78180,499 shs206,842 shsIVCInvacare$0.50$0.33▼$2.53$20.01M0.38240,305 shs33,301 shsSMTISanara MedTech$33.96-3.7%$29.59$23.53▼$39.08$314.08M1.1929,246 shs29,571 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEAREargo0.00%0.00%0.00%0.00%0.00%ESTAEstablishment Labs0.00%-4.00%-1.26%+0.08%-8.59%INGNInogen0.00%+5.30%+11.34%+36.64%-26.12%IVCInvacare0.00%0.00%0.00%0.00%0.00%SMTISanara MedTech0.00%+1.16%+11.71%+17.88%+1.34%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEAREargo$70.50$52.85$1.47▼$8.48$1.46B1.523,347 shsN/AESTAEstablishment Labs$37.47-0.9%$40.85$26.56▼$50.85$1.10B0.85255,286 shs313,935 shsINGNInogen$8.54-0.2%$7.27$5.70▼$12.91$231.47M1.78180,499 shs206,842 shsIVCInvacare$0.50$0.33▼$2.53$20.01M0.38240,305 shs33,301 shsSMTISanara MedTech$33.96-3.7%$29.59$23.53▼$39.08$314.08M1.1929,246 shs29,571 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEAREargo0.00%0.00%0.00%0.00%0.00%ESTAEstablishment Labs0.00%-4.00%-1.26%+0.08%-8.59%INGNInogen0.00%+5.30%+11.34%+36.64%-26.12%IVCInvacare0.00%0.00%0.00%0.00%0.00%SMTISanara MedTech0.00%+1.16%+11.71%+17.88%+1.34%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEAREargo 0.00N/AN/AN/AESTAEstablishment Labs 2.83Moderate Buy$56.5050.79% UpsideINGNInogen 2.50Moderate Buy$11.0028.81% UpsideIVCInvacare 0.00N/AN/AN/ASMTISanara MedTech 3.00Buy$50.0047.23% UpsideCurrent Analyst Ratings BreakdownLatest ESTA, INGN, IVC, EAR, and SMTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/20/2025ESTAEstablishment LabsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$60.008/18/2025SMTISanara MedTechHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$53.00 ➝ $54.008/18/2025SMTISanara MedTechHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$53.00 ➝ $54.007/16/2025ESTAEstablishment LabsMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$58.00 ➝ $70.007/9/2025ESTAEstablishment LabsCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$38.00 ➝ $47.006/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$14.006/13/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$48.00(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEAREargo$41.11M35.61N/AN/A$4.87 per share14.48ESTAEstablishment Labs$177.42M6.12N/AN/A$1.90 per share19.72INGNInogen$335.70M0.69N/AN/A$7.30 per share1.17IVCInvacare$872.46M0.00N/A0.77$5.54 per share0.00SMTISanara MedTech$97.24M3.11N/AN/A$4.45 per share7.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEAREargo-$157.49M-$7.52N/A∞N/A-263.14%-135.08%-96.37%N/AESTAEstablishment Labs-$84.60M-$3.05N/AN/AN/A-49.89%-224.34%-25.53%11/6/2025 (Estimated)INGNInogen-$35.89M-$1.06N/AN/AN/A-7.58%-13.77%-8.52%11/6/2025 (Estimated)IVCInvacare-$45.56M-$2.18N/AN/AN/A-9.99%-37.76%-7.18%N/ASMTISanara MedTech-$9.66M-$1.16N/AN/AN/A-10.22%-26.43%-10.69%11/11/2025 (Estimated)Latest ESTA, INGN, IVC, EAR, and SMTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025SMTISanara MedTech-$0.33-$0.23+$0.10-$0.23$25.15 million$25.83 million8/7/2025Q2 2025ESTAEstablishment Labs-$0.54-$0.57-$0.03-$0.57$50.80 million$51.30 million8/7/2025Q2 2025INGNInogen-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEAREargoN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/AIVCInvacareN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEAREargoN/A3.222.97ESTAEstablishment Labs9.712.841.67INGNInogenN/A3.032.67IVCInvacare4.821.320.78SMTISanara MedTech1.252.262.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEAREargo80.53%ESTAEstablishment Labs72.91%INGNInogen89.94%IVCInvacare59.87%SMTISanara MedTech8.10%Insider OwnershipCompanyInsider OwnershipEAREargo0.81%ESTAEstablishment Labs11.09%INGNInogen1.46%IVCInvacare6.90%SMTISanara MedTech42.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEAREargo24320.76 million20.59 millionNot OptionableESTAEstablishment Labs1,01828.97 million25.76 millionOptionableINGNInogen1,03027.04 million26.65 millionOptionableIVCInvacare3,00037.76 million35.15 millionOptionableSMTISanara MedTech608.90 million5.11 millionNot OptionableESTA, INGN, IVC, EAR, and SMTI HeadlinesRecent News About These CompaniesNuveen LLC Purchases New Shares in Sanara MedTech Inc. $SMTISeptember 8, 2025 | marketbeat.comWall Street Zen Upgrades Sanara MedTech (NASDAQ:SMTI) to "Buy"September 7, 2025 | americanbankingnews.comSanara MedTech: Growth Remains Strong As Debt Concerns RecedeSeptember 4, 2025 | seekingalpha.comSanara MedTech stock falls after CEO succession announcementSeptember 3, 2025 | za.investing.comSanara MedTech Shares Dip Following CEO Succession AnnouncementSeptember 3, 2025 | msn.comSeth Yon Named CEO of Sanara MedTech Inc., Ron Nixon to Remain Executive ChairmanSeptember 2, 2025 | quiverquant.comQSanara MedTech Inc. Announces Chief Executive Officer TransitionSeptember 2, 2025 | globenewswire.comAnalysts Expect Breakeven For Sanara MedTech Inc. (NASDAQ:SMTI) Before LongSeptember 1, 2025 | finance.yahoo.comSanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025August 27, 2025 | globenewswire.comSanara Medtech Inc News (SMTI) - Investing.comAugust 23, 2025 | investing.comQ3 EPS Estimates for Sanara MedTech Boosted by HC WainwrightAugust 22, 2025 | marketbeat.comHC Wainwright Forecasts Sanara MedTech Q1 EarningsAugust 21, 2025 | marketbeat.comFY2025 EPS Estimate for Sanara MedTech Raised by AnalystAugust 19, 2025 | marketbeat.comSanara MedTech price target raised to $54 from $53 at H.C. WainwrightAugust 18, 2025 | msn.comSanara MedTech (NASDAQ:SMTI) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPSAugust 16, 2025 | marketbeat.comSanara MedTech Reports Strong Revenue Growth in Q2 2025August 14, 2025 | msn.comSanara MedTech Inc. (NASDAQ:SMTI) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | msn.comSanara MedTech Inc. (SMTI) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comSanara MedTech Sales Jump 28 PercentAugust 13, 2025 | theglobeandmail.comSanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue EstimatesAugust 13, 2025 | zacks.comSanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)August 13, 2025 | globenewswire.comMedia Sentiment Over Time Top HeadlinesView All Headlines3 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025Can Identity Security Fuel CrowdStrike’s Next Growth Phase?By Chris Markoch | August 22, 2025ESTA, INGN, IVC, EAR, and SMTI Company DescriptionsEargo NASDAQ:EAREargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.Establishment Labs NASDAQ:ESTA$37.47 -0.34 (-0.90%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$37.49 +0.02 (+0.07%) As of 09/12/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Inogen NASDAQ:INGN$8.54 -0.02 (-0.23%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$8.54 0.00 (-0.06%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Invacare NYSE:IVCInvacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.Sanara MedTech NASDAQ:SMTI$33.96 -1.32 (-3.74%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$33.98 +0.02 (+0.05%) As of 09/12/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
